| Title |
Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma
|
|---|---|
| Published in |
BMC Cancer, November 2020
|
| DOI | 10.1186/s12885-020-07503-y |
| Pubmed ID | |
| Authors |
Rafael Fonseca, Saad Z. Usmani, Maneesha Mehra, Mary Slavcev, Jianming He, Sarah Cote, Annette Lam, Jon Ukropec, Eric M. Maiese, Sandhya Nair, Ravi Potluri, Peter M. Voorhees |
X Demographics
The data shown below were collected from the profiles of 49 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 25 | 51% |
| Korea, Republic of | 1 | 2% |
| Argentina | 1 | 2% |
| Sweden | 1 | 2% |
| Chile | 1 | 2% |
| Canada | 1 | 2% |
| India | 1 | 2% |
| Unknown | 18 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 20 | 41% |
| Scientists | 19 | 39% |
| Practitioners (doctors, other healthcare professionals) | 8 | 16% |
| Science communicators (journalists, bloggers, editors) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 54 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 20% |
| Unspecified | 5 | 9% |
| Other | 3 | 6% |
| Student > Doctoral Student | 3 | 6% |
| Student > Ph. D. Student | 3 | 6% |
| Other | 6 | 11% |
| Unknown | 23 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 22% |
| Unspecified | 5 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
| Arts and Humanities | 2 | 4% |
| Nursing and Health Professions | 2 | 4% |
| Other | 8 | 15% |
| Unknown | 22 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 469. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2024.
All research outputs
#60,109
of 26,156,431 outputs
Outputs from BMC Cancer
#4
of 9,207 outputs
Outputs of similar age
#1,827
of 438,586 outputs
Outputs of similar age from BMC Cancer
#1
of 131 outputs
Altmetric has tracked 26,156,431 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,207 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,586 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 131 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.